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Background: Anogenital distance (AGD) in animals is a sensitive biomarker of fetal endocrine 
disruption and the associated testicular dysgenesis syndrome (TDS). However, AGD in human 
infants with cryptorchidism and hypospadias, which are potential manifestations of TDS during 
childhood, is not clearly described.
oBjective: Our aim was to compare AGD in boys with cryptorchidism or hypospadias against 
normative data.
Methods: Boys with isolated cryptorchidism (n = 71, age 13.4 ± 5.8 months) or hypospadias 
(n = 81, age 11.4 ± 6.2 months) were recruited from a tertiary center for measurement of AGD and 
penile length; they were compared with 487 healthy full-term boys from a birth cohort by deriving 
age-specific standard deviation scores (SDS).
results: Boys with cryptorchidism were older (p = 0.048) compared with boys with hypospadias. 
Boys with hypospadias had shorter mean AGD and penile length SDS than healthy boys (both 
p < 0.0001). Mean AGD and penile length SDS values in boys with cryptorchidism were longer 
than mean values in boys with hypospadias (both p < 0.01) and shorter than mean values in healthy 
boys (both p < 0.0001). Mean penile length SDS decreased as the severity of hypospadias increased 
(ptrend = 0.078).
conclusions: In the study population, AGD and penile length were reduced in boys with hypo-
spadias or cryptorchidism relative to normative data derived from a longitudinal birth cohort. The 
findings support the use of AGD as a quantitative biomarker to examine the prenatal effects of 
exposure to endocrine disruptors on the development of the male reproductive tract.
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Hughes IA. 2014. Anogenital distance and penile length in infants with hypospadias or cryptor-
chidism: comparison with normative data. Environ Health Perspect 122:207–211; http://dx.doi.
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Introduction
Declining secular trends in male reproductive 
health with increasing incidence of cryptor-
chidism, hypospadias, testicular cancer, and 
reduced sperm quality have been reported by 
several epidemiological studies in many coun-
tries (Acerini and Hughes 2006; Diamanti-
Kandarakis et al. 2009; Toppari et al. 2010; 
Wohlfahrt-Veje et al. 2009b). Geographical 
variation in the incidences of these conditions 
suggests exposure to environmental agents 
as a possible causative factor (Boisen et al. 
2004). Furthermore, the four disorders are 
associated with each other and postulated to 
be the manifestation of an underlying entity 
known as testicular dysgenesis syndrome 
(TDS). Hypospadias and cryptorchidism 
are potential manifestations of TDS at birth. 
Exposure to environmental chemicals that 
act as endocrine disruptors has been pro-
posed as one of the pathogenetic mechanisms 
underlying abnormal fetal testicular develop-
ment that characterizes TDS (Skakkebaek 
et al. 2001; Wohlfahrt-Veje et al. 2009b). 
This is supported by several animal studies 
(Dean et al. 2012; van den Driesche et al. 
2012). Measurement of anogenital distance 
(AGD) has been proposed as a quantitative 
biomarker of fetal endocrine disruptor 
 exposure in humans (Arbuckle et al. 2008).
AGD is a marker of perineal growth and 
caudal migration of the genital tubercle, 
and is androgen dependent in male rodents 
(Bowman et al. 2003). In animal studies, 
AGD measured from the genital tubercle to 
the anus is a sensitive marker of in utero expo-
sure to androgens and anti-androgens, and 
is used extensively in animal reproductive 
toxicology studies (McIntyre et al. 2001). 
Shorter AGD in human infants has been 
associated with prenatal exposure to a vari-
ety of environmental chemicals (Miao et al. 
2011; Swan et al. 2005; Torres-Sanchez et al. 
2008). Reduced AGD has also been proposed 
as a marker of testicular dysfunction in adult 
men (Eisenberg et al. 2011; Mendiola et al. 
2011). Establishing the alterations in AGD in 
cryptorchidism and hypospadias—the most 
common genital anomalies at birth in boys—
is important in determining the role of AGD 
as a biomarker of fetal endocrine disruption 
and TDS in humans.
Some cross-sectional studies have reported 
shorter weight-adjusted AGD in boys with 
cryptorchidism, and shorter AGD in boys with 
hypospadias (Hsieh et al. 2008, 2012; Swan 
et al. 2005). However, the  studies relied on 
derivatives of AGD to adjust for age-related 
changes in AGD in the absence of norma-
tive data (Swan 2006) and used measurements 
performed under anesthesia (Hsieh et al. 2008, 
2012). Recently we and others have published 
normative data for AGD during infancy based 
on large population studies (Papadopoulou 
et al. 2013; Thankamony et al. 2009). Both 
studies reported a characteristic nonlinear 
pattern of rapid growth in the first year and 
little change thereafter. Therefore, applying 
normative data is useful in further character-
izing AGD in these disorders, as highlighted 
in a recent review (Dean and Sharpe 2013). 
In the present study, we compared age-specific 
standard deviation scores (SDS) for AGD and 
penile length in boys with isolated cryptor-
chidism or cryptorchidism to normative data 
from a cohort of healthy boys.
Methods
Study population. Boys < 2 years of age with 
isolated hypospadias or cryptorchidism were 
recruited from pediatric surgery outpatient and 
pre-operative assessment clinics at Cambridge 
University Hospital NHS Foundation Trust, 
Cambridge, United Kingdom, between 2010 
and 2012. Children with anogenital malfor-
mations, which prevented identification of 
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anatomical landmarks for measuring AGD, 
and in whom genital anomalies were a part 
of a malformation syndrome, were excluded. 
Controls were healthy full term-born boys 
(born > 37 weeks, birth weight > 2,500 g) 
from the Cambridge Baby Growth Study 
(CGBS) who had normal genitalia. In brief, 
CBGS is a longitudinal study established in 
2001 to characterize hormonal, genetic, and 
environmental influences on infant growth 
and early male reproductive development 
(Thankamony et al. 2009). Measurement of 
AGD was included in the CBGS study proto-
col from 2006 onward. Mothers gave written 
informed consent for their infants to partici-
pate in the study. The research protocol was 
approved by the Cambridge Local Research 
Ethics Committee, and the study was con-
ducted in accordance with the International 
Conference on Harmonization standards for 
Good Clinical Practice.
Measurements. Infants in the CBGS 
were measured at birth and at 3, 12, 18, and 
24 months of age by trained pediatric nurses 
(Thankamony et al. 2009). Hypospadias and 
cryptorchidism cases had one set of AGD, 
weight, body length, and penile length 
measure ments taken before age 2 years when 
they attended outpatient clinics. The same 
trained nurses performed the measurements in 
both cases and controls using the same proto-
cols, which have been reported previously 
(Thankamony et al. 2009). Briefly, AGD was 
measured from the center of the anus to the 
junction between smooth perineal skin and 
rugated skin of the scrotum using Vernier 
calipers (DialMax; Wiha Premium Tools, 
Schonach, Germany). Penile length was mea-
sured from the lower edge of the pubic bone 
to the tip of the flaccid penis using Vernier 
calipers. Three consecutive measurements were 
taken at each assessment, and the average was 
used for analysis.
Statistics. Because the AGD and penile 
length increase substantially with age dur-
ing early infancy, we generated normative 
data for AGD and penile length from the 
CBGS and calculated age-adjusted SDS. 
Reference centile curves were computed with 
the LMS (lambda-mu-sigma) method by 
Cole (Cole et al. 2011), using the software 
LMSchartmaker Light (Cole et al. 2011; Pan 
and Cole 2011). The LMS method is based 
on the use of Box–Cox transformations to 
normality through the calculation of a skew-
ness parameter. The LMS parameters are the 
power in the Box–Cox transformation (L), 
the median (M), and the generalized coeffi-
cient of variation (S). Given these parameters 
and the assumption that the residuals follow 
a normal distribution, any desired percentile 
can be calculated. The LMS values for AGD 
and penile length derived from CBGS were 
used to calculate age-specific SDS employing 
the LMSgrowth software (Cole et al. 2011; 
Pan and Cole 2012). Age- and gender-specific 
SDS for weight and body length measure-
ments were calculated by comparison to UK 
normative data (Freeman et al. 1995). All 
SDS calculations were adjusted for gestational 
age at birth. In CBGS boys who underwent 
longitudinal assessments, an average of the 
age and SDS of the measurements across 
multiple visits was used for analysis. Paired 
outcomes between the groups were compared 
using Student’s t-test. AGD is associated with 
weight (Swan et al. 2005); hence, weight SDS 
was used as a covariate in multivariable linear 
models (version 18.0; SPSS for Windows, 
IBM, Chicago, IL, USA). An association 
between penile length and severity of hypo-
spadias based on the position of urethral 
meatus was reported in adults (Bracka 1989). 
Therefore, we evaluated linear trends in AGD 
and penile length among the subgroups of 
hypospadias with increasing grades of severity 
(glanular/subcoronal, penile, and perineal) 
by coding the subgroups using integer scores 
(1, 2, and 3 respectively) and analyzing using 
one-way analysis of variance (ANOVA). 
The data are expressed as mean ± SD unless 
otherwise specified. Also included (see 
Supplemental Material, Table S1) are LMS 
values of AGD and penile length derived 
from the CBGS at monthly intervals, which 
can be used to generate SDS in other popula-
tions using freely available LMSgrowth soft-
ware (Cole et al. 2011; Pan and Cole 2012). 
Results
Data were collected in 154 boys with genital 
abnormalities; two boys had both hypospadias 
and cryptorchidism and were excluded from 
the study. The details of the remaining 81 
boys with hypospadias, 71 with cryptorchi-
dism, and 487 healthy boys from CBGS are 
shown in Table 1. Most of the healthy boys 
(96.1%), boys with hypospadias (94.4%), 
and boys with cryptorchidism (94.8%) were 
Caucasian. Boys in the CBGS were measured 
longitudinally on 3.5 ± 1.5 occasions.
Hypospadias. Hypospadias was glanu-
lar or subcoronal, penile, or perineal in 51 
(62.9%), 22 (27.2%), and 8 (9.9%) boys, 
respectively. Although five boys with 
hypospadias had had previous genital sur-
gery, all had penile hypospadias, the sur-
gical repair of which is less likely to affect 
AGD measure ments. The mean age of boys 
with hypo spadias was similar to the age of 
healthy boys averaged across multiple visits 
(Table 1). The age distribution suggested 
two distinct time points for assessment: early 
infancy (< 6 months) and around 1 year 
(Figure 1). Boys with hypospadias had lower 
mean birth weight SDS (p = 0.001). They 
also had reduced current weight SDS com-
pared with the weight SDS of healthy boys 
averaged across multiple visits, although the 
difference was not statistically significant 
(p = 0.087). The AGD SDS and penile length 
SDS of boys with hypospadias were signifi-
cantly reduced compared with healthy boys 
(both p < 0.0001) (Table 1, Figures 1 and 2). 
AGD SDS was associated with current 
weight SDS in the entire cohort of subjects 
(r = 0.18, p < 0.0001); however, adjust-
ing for weight SDS did not alter the results 
(unadjusted data not shown). Increasing 
severity of hypospadias was associated with 
a nonsignificant trend for reductions in 
Table 1. Characteristics of healthy controls and patients with cryptorchidism and hypospadias (mean ± SD or p-value).
Characteristic Healthy boysa Cryptorchidism Hypospadias
Cryptorchidism vs. 
healthy boys
Hypospadias vs. 
healthy boys
Cryptorchidism vs. 
hypospadias
Observations (n) 487 71 81
Gestational age (weeks) 40.05 ± 1.20 38.95 ± 2.60 38.26 ± 3.27 < 0.0001 < 0.0001 0.21
Birth weight SDS 0.03 ± 0.88 –0.07 ±1.12 –0.39 ± 1.37 0.47 0.001 0.26
Age (months) 11.46 ± 6.23 13.43 ± 5.79 11.45 ± 6.15 0.012 0.98 0.048
Weight (kg) 8.81 ± 2.70 10.30 ± 2.02 9.15 ± 2.71 — — —
Body length (cm) 71.77 ± 10.21 76.16 ± 6.87 73.42 ± 10.16 — — —
AGD (mm) 29.75 ± 6.97 29.09 ± 6.78 24.65 ± 6.27 — — —
Penile length (mm) 36.09 ± 5.17 35.30 ± 5.89 28.70 ± 7.48 — — —
Weight SDS 0.01 ± 0.96 0.15 ± 1.26 –0.21 ± 1.46 0.24 0.087 0.037
Body Length SDS 0.29 ± 0.93 0.21 ± 1.49 0.10 ± 1.43 0.52 0.12 0.66
AGD SDSb 0.03 ± 0.77 –0.48 ± 0.93 –0.90 ± 0.89 < 0.0001 < 0.0001 0.005
Penile length SDSb –0.02 ± 0.82 –0.35 ± 1.03 –1.34 ± 1.28 0.002 < 0.0001 < 0.0001
—, comparison not performed.
aThe values of healthy boys were derived from the average of measurements/SDS values across multiple visits. Because the measurements vary with age, only the SDS values of the 
 measurements were analyzed. bAdjusted for weight SDS. 
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penile length SDS (glanular or subcoronal: 
–1.15 ± 1.10; penile: –1.57 ± 1.64; peri-
neal: –2.19 ± 1.01; ptrend = 0.077) and AGD 
SDS (glanular or subcoronal: –0.82 ± 0.97; 
penile: –0.92 ± 0.75; perineal: –1.43 ± 0.87; 
ptrend = 0.21).
Cryptorchidism. Bilateral undescended 
testes were present in 13 boys (18.3%) with 
cryptorchidism. Boys with cryptorchidism 
(bilateral and unilateral) were assessed over a 
wider age range than boys with hypo spadias, 
with a peak at 1 year (Figure 1). The mean age 
of the boys with cryptorchidism was higher 
than that of healthy boys (p = 0.012), the lat-
ter derived from the average across multiple 
visits. Mean values for birth weight, weight 
at measurement, and body length SDS were 
similar between the cryptorchid boys and 
controls. Mean AGD SDS (p < 0.0001) and 
penile length SDS (p = 0.002) both were 
lower in cryptorchid boys than in healthy con-
trols (Table 1, Figures 1 and 2). Mean AGD 
and penile length SDS were similar in boys 
with unilateral and bilateral cryptorchidism 
(data not shown).
Hypospadias compared with cryptorchi-
dism. Mean birth weight SDS of boys with 
hypospadias was lower than that of the 
boys with cryptorchidism (p = 0.051). Boys 
with hypospadias also had lower mean age 
(p = 0.048) and weight SDS (p = 0.037), but 
mean body length SDS was similar in both 
groups. Mean AGD SDS (p = 0.005) and 
penile length SDS (p < 0.0001) values also 
were lower for boys with hypospadias than for 
cryptorchid boys (Table 1, Figures 1 and 2).
Correlations between AGD and penile 
length. In healthy controls, AGD SDS was 
weakly correlated with penile length SDS 
(r = 0.09, p = 0.061). In contrast, AGD SDS 
and penile length SDS were more strongly 
correlated among boys with cryptorchi-
dism (r = 0.31, p = 0.008) and hypospadias 
(r = 0.33, p = 0.003).
Discussion
In this study, mean AGD and penile length 
parameters were significantly lower in boys 
with hypospadias or cryptorchidism than in 
healthy controls from a large birth cohort. 
Boys with cryptorchidism had intermedi-
ate AGD and penile length values, which 
suggest gradations in the severity of the 
endocrine disruption that has been hypoth-
esized to underlie these conditions (Dean and 
Sharpe 2013).
Isolated hypospadias and cryptorchidism 
are the most common congenital urogenital 
abnormalities, with an incidence of 0.2–1% 
and 2–9% respectively (Toppari et al. 2010). 
Although their etiology remains poorly 
understood, they share similar risk factors and 
are postulated to be manifestations at birth 
of an underlying TDS (Skakkebaek et al. 
2001). Large population studies showing 
higher incidence of hypospadias and cryptor-
chidism associated with parental exposures to 
pesticides and other environmental chemicals 
suggest a role for environmental endocrine 
disruptors in the pathogenetic mechanisms 
(Damgaard et al. 2006; Gaspari et al. 2011; 
Hosie et al. 2000; Toppari et al. 2010; 
Weidner et al. 1998). Epidemiological links 
of hypospadias and cryptorchidism with 
reduced fertility (Skakkebaek et al. 2001), and 
the observations of reduced insulin-like fac-
tor 3 (INSL3) (Bay et al. 2007) and increased 
gonadotropin levels (Suomi et al. 2006) in 
cryptorchid boys compared with healthy boys 
supports an associated testicular dysfunction 
in these disorders. Furthermore, both condi-
tions are common manifestations of androgen 
receptor mutations in humans, and can be 
induced in animals by chemicals that affect 
testis development or function (Kalfa et al. 
2009; Toppari 2008; Toppari et al. 2010).
Based on animal model studies con-
ducted in rats, the reduction in AGD is anti-
androgen dose dependent and is associated 
with outcomes such as reduced penile length, 
hypospadias, cryptorchidism, and low sperm 
production (Dean and Sharpe 2013; Gray 
et al. 1999). A “male programming window” 
during fetal development (E15.5–E19.5) has 
also been identified in rats, during which for-
mation of the external genitalia appears to be 
particularly susceptible to the effects of chem-
icals acting as endocrine disruptors (Welsh 
et al. 2008). In contrast to rodents, the genital 
tubercle in the human is already differentiated 
as a penis or clitoris at birth. In the present 
Figure 1. Distribution of AGD and penile length in boys with hypospadias (A,C) or cryptorchidism (B,D) 
against centile lines (3rd, 10th, 25th, 50th, 75th, 90th, and 97th centiles) from normative data. 
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boys and those with cryptorchidism or hypospa-
dias. The values of healthy boys were derived from 
the average of SDS values across multiple vis-
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compared with controls (both p < 0.01). Error bars 
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study we used the perineoscrotal junction as 
the anterior landmark to measure the distance 
from the anus. It is readily identified and 
reflects the caudal border of the genital swell-
ing that later differentiates into a scrotum 
(Salazar-Martinez et al. 2004). The observa-
tions of a longer AGD in girls with viriliz-
ing congenital adrenal hyperplasia (Callegari 
et al. 1987) and reports of reduced AGD in 
adult males with lower testosterone levels 
(Eisenberg et al. 2012a), semen quality, and 
fertility rates (Eisenberg et al. 2011, 2012b; 
Mendiola et al. 2011) support animal experi-
mental data that suggest that this anthropo-
metric measurement represents a long-term 
biomarker of the effects of fetal testicular 
function (Dean and Sharpe 2013). Reports 
of shorter AGD in male infants related to 
prenatal exposure to environmental chemicals 
such as phthalates (Suzuki et al. 2012; Swan 
et al. 2005), bisphenol A (Miao et al. 2011), 
and dioxins (Vafeiadi et al. 2012) support the 
utility of this measurement as a biomarker of 
endocrine disruption in humans.
That the present study has established 
an association between AGD with congeni-
tal genital abnormalities, which have been 
proposed as important clinical outcomes of 
TDS, supports the use of the measurement 
as a biomarker of fetal endocrine disruption. 
A previous cross-sectional study designed to 
determine an association of AGD with pre-
natal phthalate exposure showed that boys 
with undescended testes had a shorter age-
adjusted anogenital index (AGI), the latter cal-
culated as the ratio of AGD to weight (Swan 
et al. 2005). Another study compared AGD 
measurements obtained under anesthesia in 
boys with cryptorchidism (n = 32) or hypo-
spadias (n = 47) and in 40 controls under-
going surgery for other urological conditions 
(Hsieh et al. 2008). AGD was reduced in boys 
with hypospadias. A significant decrease was 
also observed for boys with cryptorchidism 
only after adjusting for weight. The subject 
groups were unmatched for age, but in a sub-
sequent study, age-matched controls of the 
same racial origin were used, and reduced 
AGD was found in boys with hypospadias 
(Hsieh et al. 2012). AGD measurement under 
anesthesia does have an advantage of increased 
reliability, but is less suitable for larger epi-
demiological studies. The advantages of the 
present study include a larger clinical sample 
size with healthy controls derived from a well-
characterized birth cohort and the applica-
tion of age-appropriate population-derived 
normative data. The well-established protocol 
of measurement was also used in the present 
study (Salazar-Martinez et al. 2004).
A reduction in both penile length and 
AGD in boys with hypospadias compared 
with those with cryptorchidism suggests a 
more severe and time-specific disruption of 
genital development in the former group. 
This is also in keeping with androgen dys-
function occurring during the proposed 
male programming window in hypospadias, 
whereas the androgen influence on testis 
descent occurs during the latter part of gesta-
tion (Hughes and Acerini 2008). A positive 
association between AGD and penile length 
in cryptorchidism or hypospadias observed 
in this study suggests that some boys with 
either of these conditions have more severe 
reductions in both of these putative androgen 
sensitive biomarkers. A link between quanti-
tative reductions in AGD and fetal androgen 
deprivation has been suggested in male repro-
ductive disorders at birth (Dean and Sharpe 
2013). Such a potential relationship would 
need to be tested in studies exploring prenatal 
exposures and genital disorders at birth.
Previous studies used regression models 
or estimated AGI to adjust for changes in 
AGD with age and body size (Hsieh et al. 
2008; Swan 2006). However, we observed 
in an earlier longitudinal study that weight 
is not related to AGD in older male infants 
(Thankamony et al. 2009). Furthermore, 
nonlinear changes in AGD with growth dur-
ing the first 2 years of life have been reported 
(Papadopoulou et al. 2013; Thankamony 
et al. 2009).
 These reports highlight the potential 
advantages of using normative data of AGD 
in cross-sectional studies. Boys with hypo-
spadias tended to have lower weight com-
pared with controls in the present study, 
although no differences were observed in 
previous smaller studies (Hsieh et al. 2011). 
Nevertheless, the differences in AGD and 
penile length persisted following adjust-
ment for weight. A potential drawback of 
the study design was whether a selection bias 
occurred as we studied referred cases; these 
may represent more severe forms of genital 
disorders. There were insufficient data to 
explore whether the type of cryptorchidism 
was congenital or acquired, the latter variety 
accounting for about half of children with 
cryptorchidism in population studies (Acerini 
et al. 2009; Wohlfahrt-Veje et al. 2009a).
Conclusions
In our study population, AGD and penile 
length were significantly lower in boys with 
hypospadias or cryptorchidism than in 
healthy boys. Our observations are based 
on the study of a relatively large group of 
subjects, using comparative normative data 
derived from a contemporary birth cohort 
study. The findings support the utility of 
AGD as a biomarker in determining the 
effects of disruption to androgen function 
during fetal development (Dean and Sharpe 
2013). The supposition that exposure to 
endocrine disruptors underlies changing 
trends in common genital birth anomalies 
can now be tested more reliably in population 
studies with validated measurements of AGD.
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